Amivantamab Biosimilar Antibody, Research Grade (EGFR/c-Met)
Amivantamab is a research-grade recombinant antibody targeting HER1. Produced in mammalian cells, it features native-like glycosylation and is suitable for PK/PD studies, assay development, and ADA research.
Product Specifications
Product Name Alternative
HER1, Receptor tyrosine-protein kinase erbB-1, Proto-oncogene c-ErbB-1, Epidermal growth factor receptor, EGFR, ERBB1, ERBB, Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET
UniProt
P00533, P08581
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA370656 100 µL
Seryl tRNA synthetase (SARS) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
MBS7060368 Inquire
Recombinant Prochlorothrix hollandica Cytochrome b6 (petB), partial
Sign In for Pricing
View Details 